|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn623574397 |
003 |
OCoLC |
005 |
20231117033133.0 |
006 |
m o d |
007 |
cr bn||||||abp |
007 |
cr bn||||||ada |
008 |
100519s1993 enka ob 001 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d UIU
|d OCLCQ
|d IDEBK
|d OCLCF
|d OPELS
|d YDXCP
|d OCLCQ
|d CHVBK
|d YDX
|d OCLCQ
|d OCLCA
|d UKAHL
|d LUN
|d INARC
|d OCLCQ
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 608510623
|a 984605952
|a 1100964525
|a 1164836434
|
020 |
|
|
|a 9781483288109
|
020 |
|
|
|a 1483288102
|
020 |
|
|
|z 9780120790357
|q (alk. paper)
|
020 |
|
|
|z 0120790351
|q (alk. paper)
|
035 |
|
|
|a (OCoLC)623574397
|z (OCoLC)608510623
|z (OCoLC)984605952
|z (OCoLC)1100964525
|z (OCoLC)1164836434
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a RM333.5
|b .A58 1993
|
060 |
|
4 |
|a 1993 A-782
|
060 |
|
4 |
|a QV 77.9
|b A63285 1993
|
082 |
1 |
4 |
|a 615.5
|2 12
|
082 |
0 |
4 |
|a 615/.788
|2 20
|
084 |
|
|
|a 44.42
|2 bcl
|
084 |
|
|
|a XI 5820
|2 rvk
|
245 |
0 |
0 |
|a Antipsychotic drugs and their side-effects /
|c edited by Thomas R.E. Barnes.
|
260 |
|
|
|a London ;
|a San Diego :
|b Academic Press,
|c �1993.
|
300 |
|
|
|a 1 online resource (xvi, 287 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Neuroscience perspectives
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a 12. Maintenance antipsychotic medication / J.M. Davis, P.G. Janicak, A. Singla and R.P. Sharma -- 13. Depot neuroleptics / D.A.W. Johnson -- 14. The side-effects of antipsychotic drugs. I. CNS and neuromuscular effects / T.R.E. Barnes and J.G. Edwards -- 15. The side-effects of antipsychotic drugs. II. Effects on other physiological systems / J.G. Edwards and T.R.E. Barnes.
|
520 |
|
|
|a Neuroscience Perspectives provides multidisciplinary reviews of topics in one of the most diverse and rapidly changing fields in the life sciences. Whether you are a new recruit to neuroscience, or an established expert, look to this series for 'one-stop' sources of the historical, physiological, pharmacological, biochemical, molecular biological and therapeutic aspects of chosen research areas.
|
520 |
8 |
|
|a Over the past 40 years, the effectiveness of conventional neuroleptic agents for psychotic illness has been offset by a wide range of adverse side-effects, including movement disorders like parkinsonism and akathisia; although, in many cases, these can be minimised by titration to the minimum effective dose.
|
520 |
8 |
|
|a However, the introduction of the atypical neuroleptic, clozapine, with a lower liability for motor side-effects, and efficacy for both positive and negative symptoms in patients unresponsive to conventional neuroleptics raised expectations of effective medication with fewer adverse effects. Further, with the identification and characterization of multiple dopamine receptors, the possibility of more selective drugs with an inherently better side-effect potential has arisen.
|
520 |
8 |
|
|a This volume covers both the basic science of neuroleptic drugs and their clinical use. The pharmacology of the conventional and atypical drugs is reviewed, as well as the pharmacokinetics, effects on neuronal and synaptic structure and the contribution of brain imaging techniques to our understanding of the effects of antipsychotic drugs on brain function. The clinical indications for these agents are discussed, as well as their use in both acute and maintenance therapy in psychotic illness.
|
520 |
8 |
|
|a The advantages and disadvantages of depot preparations and the broad range of potential side-effects are also considered.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
588 |
0 |
|
|a Print version record.
|
650 |
|
0 |
|a Psychotropic drugs
|x Side effects.
|
650 |
|
0 |
|a Psychotropic drugs
|x Complications.
|
650 |
1 |
2 |
|a Antipsychotic Agents
|x pharmacology
|0 (DNLM)D014150Q000494
|
650 |
2 |
2 |
|a Antipsychotic Agents
|x adverse effects
|0 (DNLM)D014150Q000009
|
650 |
2 |
2 |
|a Antipsychotic Agents
|x therapeutic use
|0 (DNLM)D014150Q000627
|
650 |
|
6 |
|a Psychotropes
|x Effets secondaires.
|0 (CaQQLa)201-0167496
|
650 |
|
6 |
|a Psychotropes
|0 (CaQQLa)201-0001454
|x Complications et s�equelles.
|0 (CaQQLa)201-0374854
|
650 |
|
7 |
|a Psychotropic drugs
|x Complications.
|2 fast
|0 (OCoLC)fst01081828
|
650 |
|
7 |
|a Psychotropic drugs
|x Side effects.
|2 fast
|0 (OCoLC)fst01081840
|
650 |
|
7 |
|a Arzneimittelnebenwirkung
|2 gnd
|0 (DE-588)4003134-2
|
650 |
|
7 |
|a Psychopharmakon
|2 gnd
|0 (DE-588)4047729-0
|
650 |
1 |
7 |
|a Antipsychotische geneesmiddelen.
|2 gtt
|
650 |
1 |
7 |
|a Bijwerkingen.
|2 gtt
|
650 |
|
7 |
|a Drogas de abuso (complica�c�oes)
|2 larpcal
|
650 |
|
7 |
|a Antipsic�oticos (aplica�c�oes terap�euticas)
|2 larpcal
|
650 |
|
7 |
|a Drogas de abuso (efeitos)
|2 larpcal
|
650 |
|
7 |
|a Antipsic�oticos (farmacologia)
|2 larpcal
|
653 |
0 |
|
|a Humans
|a Nervous system
|a Effects of
|a Drugs
|
700 |
1 |
|
|a Barnes, Thomas R. E.
|
776 |
0 |
8 |
|i Print version:
|t Antipsychotic drugs and their side-effects.
|d London ; San Diego : Academic Press, �1993
|w (OCoLC)29762112
|
830 |
|
0 |
|a Neuroscience perspectives.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120790357
|z Texto completo
|